Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders
Dermatologic Cooperative Oncology Group (DeCOG)
Clinic of Dermatology, Allergology and Venerology
University of Kiel
University of Tubingen
University of Würzburg
University of Erlangen–Nuremberg
Johannes Gutenberg University Mainz
Technische Universität Dresden
University of Freiburg
Saarland University
University of Cologne
Georg August University Göttingen
University of Leipzig
University of Duisburg-Essen
Hannover Medical School
4
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Autoimmune Disease
100%
Metastatic Melanoma
100%
Pancreatitis
10%
Skin Cancer
10%
Ulcerative Colitis
10%
Immunology and Microbiology
Autoimmune Disease
100%
Immunity
30%
Immunosuppressant
10%
Pancreatitis
10%
Sarcoidosis
10%
Ulcerative Colitis
10%
Pharmacology, Toxicology and Pharmaceutical Science
Autoimmune Disease
100%
Crohn's Disease
10%
Immunosuppressive Agent
10%
Remission
20%
Sarcoidosis
10%
Ulcerative Colitis
10%
Keyphrases
Cancer Center
10%
Large Series
10%
Objective Response
10%
Pancreatitis
10%
INIS
thyroiditis
7%